Araghi M, Soerjomataram I, Jenkins M, Brierley J, Morris E, Bray F, et al. Global trends in colorectal cancer mortality: projections to the year 2035. Int J cancer. 2019;144:2992–3000.

Article  PubMed  CAS  Google Scholar 

World cancer research fund international. colorectal cancer statistics: world cancer research fund international; 2022 [Available from: https://www.wcrf.org/cancer-trends/colorectal-cancer-statistics/.

American society of clinical oncology. colorectal cancer statistics: American society of clinical oncology; 2022 [Available from: https://www.cancer.net/cancer-types/colorectal-cancer/statistics.

Bando H, Ohtsu A, Yoshino T. Therapeutic landscape and future direction of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2023;20:306–22 https://doi.org/10.1038/s41575-022-00736-1.

Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330–8.

Article  PubMed  CAS  Google Scholar 

Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharm Ther. 2020;206:107447.

Article  CAS  Google Scholar 

Ghafouri-Fard S, Abak A, Tondro Anamag F, Shoorei H, Fattahi F, Javadinia SA, et al. 5-fluorouracil: a narrative review on the role of regulatory mechanisms in driving resistance to this chemotherapeutic agent. Front Oncol. 2021;11:658636.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ryan SL, Beard S, Barr MP, Umezawa K, Heavey S, Godwin P, et al. Targeting NF-kappaB-mediated inflammatory pathways in cisplatin-resistant NSCLC. Lung Cancer. 2019;135:217–27.

Article  PubMed  Google Scholar 

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.

Article  PubMed  PubMed Central  Google Scholar 

Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc: Ser B (Methodol). 1995;57:289–300.

Google Scholar 

Kildey K, Gandhi NS, Sahin KB, Shah ET, Boittier E, Duijf PHG, et al. Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy. Commun Biol. 2021;4:638.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Adams MN, Burgess JT, He Y, Gately K, Snell C, Zhang S-D, et al. Expression of CDCA3 is a prognostic biomarker and potential therapeutic target in non–small cell lung cancer. J Thorac Oncol. 2017;12:1071–84.

Article  PubMed  Google Scholar 

Spoerri L, Gunasingh G, Haass NK. Fluorescence-based quantitative and spatial analysis of tumour spheroids: a proposed tool to predict patient-specific therapy response. Front Digital Health. 2021;3:668390.

Article  Google Scholar 

Spoerri L, Tonnessen-Murray CA, Gunasingh G, Hill DS, Beaumont KA, Jurek RJ, et al. Phenotypic melanoma heterogeneity is regulated through cell-matrix interaction-dependent changes in tumor microarchitecture. bioRxiv. 2021:2020.06.09.141747.

Spoerri L, Beaumont KA, Anfosso A, Haass NK. Real-time cell cycle imaging in a 3D cell culture model of melanoma. In: Koledova Z, editor. 3D Cell Culture: Methods and Protocols. New York, NY: Springer New York; 2017. p. 401–16.

He Y, Davies CM, Harrington BS, Hellmers L, Sheng Y, Broomfield A, et al. CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin. Oncogene. 2020;39:219–33.

Article  PubMed  CAS  Google Scholar 

Naipal KA, Verkaik NS, Sánchez H, van Deurzen CH, den Bakker MA, Hoeijmakers JH, et al. Tumor slice culture system to assess drug response of primary breast cancer. BMC cancer. 2016;16:1–13.

Article  Google Scholar 

Fabregat A, Sidiropoulos K, Viteri G, Forner O, Marin-Garcia P, Arnau V, et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinforma. 2017;18:142.

Article  Google Scholar 

Ryan S-L, Dave KA, Beard S, Gyimesi M, McTaggart M, Sahin KB, et al. Identification of proteins deregulated by platinum-based chemotherapy as novel biomarkers and therapeutic targets in non-small cell lung cancer. Front Oncol. 2021;11:615967.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arora M, Kumari S, Singh J, Chopra A, Chauhan SS. PAXX, Not NHEJ1 Is an independent prognosticator in colon cancer. Front Mol Biosci. 2020;7:584053.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Riggs KA, Hasan N, Humphrey D, Raleigh C, Nevitt C, Corbin D, et al. Regulation of integrin endocytic recycling and chemotactic cell migration by syntaxin 6 and VAMP3 interaction. J Cell Sci. 2012;125:3827–39.

PubMed  PubMed Central  CAS  Google Scholar 

Song J, Liu YD, Su J, Yuan D, Sun F, Zhu J. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. J Cell Physiol. 2019;234:22753–64.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhao W, Sun L, Li X, Wang J, Zhu Y, Jia Y, et al. SCD5 expression correlates with prognosis and response to neoadjuvant chemotherapy in breast cancer. Sci Rep. 2021;11:8976.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther. 2020;206:107447.

Article  PubMed  CAS  Google Scholar 

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–d13.

Article  PubMed  CAS  Google Scholar 

Gully CP, Velazquez-Torres G, Shin J-H, Fuentes-Mattei E, Wang E, Carlock C, et al. Aurora B kinase phosphorylates and instigates degradation of p53. Proc Natl Acad Sci. 2012;109:E1513–E22.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vogel C, Hager C, Bastians H. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation. Cancer Res. 2007;67:339–45.

Article  PubMed  CAS  Google Scholar 

Trivedi P, Stukenberg PT. A condensed view of the chromosome passenger complex. Trends Cell Biol. 2020;30:676–87.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Boyer J, McLean EG, Aroori S, Wilson P, McCulla A, Carey PD, et al. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin Cancer Res. 2004;10:2158–67.

Article  PubMed  CAS  Google Scholar 

Cho Y-H, Ro EJ, Yoon J-S, Mizutani T, Kang D-W, Park J-C, et al. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. Nat Commun. 2020;11:5321.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sankhe K, Prabhu A, Khan T. Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer. Chem Biol Drug Des. 2021;98:73–93.

Article  PubMed  CAS  Google Scholar 

Azzariti A, Bocci G, Porcelli L, Fioravanti A, Sini P, Simone GM, et al. Aurora B kinase inhibitor AZD1152: determinants of action and ability to enhance chemotherapeutics effectiveness in pancreatic and colon cancer. Br J Cancer. 2011;104:769–80.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Moroz MA, Kochetkov T, Cai S, Wu J, Shamis M, Nair J, et al. Imaging colon cancer response following treatment with AZD1152: a preclinical analysis of [18F]fluoro-2-deoxyglucose and 3’-deoxy-3’-[18F]fluorothymidine imaging. Clin Cancer Res. 2011;17:1099–110.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zekri A, Ghaffari SH, Ghanizadeh-Vesali S, Yaghmaie M, Salmaninejad A, Alimoghaddam K, et al. AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy. Tumour Biol. 2015;36:623–32.

Article  PubMed  CAS  Google Scholar 

Walsby E, Walsh V, Pepper C, Burnett A, Mills K. Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts. haematologica. 2008;93:662–9.

Article  PubMed  CAS  Google Scholar 

Berrouet C, Dorilas N, Rejniak KA, Tuncer N. Comparison of Drug Inhibitory Effects (>\hbox _>) in Monolayer and Spheroid Cultures. Bulletin of Mathematical Biology. 2020;86:68.

Schwartz GK, Carvajal RD, Midgley R, Rodig SJ, Stockman PK, Ataman O, et al. Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors. Invest N. Drugs. 2013;31:370–80.

Article  CAS  Google Scholar 

Amirouchene-Angelozzi N, Swanton C, Bardelli A. Tumor evolution as a therapeutic targetthe impact of tumor evolution in precision medicine. Cancer Discov. 2017;7:805–17.

Article  Google Scholar 

Borah NA, Reddy MM. Aurora kinase B inhibition: a potential therapeutic strategy for cancer. Molecules. 2021;26:1981.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN Jr, Gandara DR. Aurora kinases as anticancer drug targets. Clin Cancer Res. 2008;14:1639–48.

Article  PubMed  CAS  Google Scholar 

Bavetsias V, Linardopoulos S. Aurora kinase inhibitors: current status and outlook. Front Oncol. 2015;5:278.